# Feifei Qi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/feifei-qi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,443 |
| Field | SARS-CoV-2 and COVID-19 Research |
| h-index | 25 |
| i10-index | 33 |
| Last Known Institution | Energy Institute |
| OpenAlex ID | https://openalex.org/A5102791418 |
| ORCID iD | 0000-0002-2937-4909 |
| Works | 60 |

## Researcher papers

- [Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion](https://scholariq.org/papers/inhibition-of-sars-cov-2-previously-2019-ncov-infection-by-a-highly-potent-pan/)
- [Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques](https://scholariq.org/papers/primary-exposure-to-sars-cov-2-protects-against-reinfection-in-rhesus-macaques/)
- [Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2](https://scholariq.org/papers/lack-of-reinfection-in-rhesus-macaques-infected-with-sars-cov-2/)
- [Age‐related rhesus macaque models of COVID‐19](https://scholariq.org/papers/age-related-rhesus-macaque-models-of-covid-19/)
- [Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy](https://scholariq.org/papers/structurally-resolved-sars-cov-2-antibody-shows-high-efficacy-in-severely/)
- [Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques](https://scholariq.org/papers/ocular-conjunctival-inoculation-of-sars-cov-2-can-cause-mild-covid-19-in-rhesus/)
- [Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19](https://scholariq.org/papers/bioactive-compounds-from-huashi-baidu-decoction-possess-both-antiviral-and-anti/)
- [<scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2](https://scholariq.org/papers/scp-microrna-scp-542-3p-inhibits-tumour-angiogenesis-by-targeting-angiopoietin-2/)
- [Compartmentalized biosynthesis of mycophenolic acid](https://scholariq.org/papers/compartmentalized-biosynthesis-of-mycophenolic-acid/)
- [Fungal-derived brevianamide assembly by a stereoselective semipinacolase](https://scholariq.org/papers/fungal-derived-brevianamide-assembly-by-a-stereoselective-semipinacolase/)
- [Targeted-release budesonide: A comprehensive review on its potential in IgA nephropathy](https://scholariq.org/papers/targeted-release-budesonide-a-comprehensive-review-on-its-potential-in-iga/)

## Researcher topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Microbial Natural Products and Biosynthesis](https://scholariq.org/topics/microbial-natural-products-and-biosynthesis/)
- [Microbial Metabolic Engineering and Bioproduction](https://scholariq.org/topics/microbial-metabolic-engineering-and-bioproduction/)

## Researcher university

- [Energy Institute](https://scholariq.org/institutions/energy-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.